Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
The Art of Medicinal Mushrooms Extraction: A Comprehensive Guide to Nature’s Powerful Remedies
Unveiling the fascinating art of medicinal mushrooms extraction, shedding light on this nuanced process and its importance in harnessing the potent health benefits of medicinal mushrooms.
Can You Combine Psychedelics and Antidepressants? A Dive into Potential Interactions and Safety
Is it safe to mix psychedelics and antidepressants like SSRIs? In this article, we look at the research to assess the potential risks.
Mindset Pharma Files Patent for Quickest, Cheapest Method to Synthesize Psilocybin
“Based on our research, we think we’re able to get to psilocybin in fewer steps than any of the other published methods,” says the company’s CEO.
Psychedelic Business Spotlight – March 18
This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.
How Nutrition Can Improve the Psychedelic Experience
Focus on these five key nutrients to better support your body and increase the likelihood of enjoying your psychedelic experience.
Study Finds Psilocybin Anti-Depression Effects Last at Least One Year
A year after a Johns Hopkins psilocybin-assisted therapy study, researchers find the number of people who benefited from receiving two doses actually increased.